XRAY financial statements and SEC filings
XRAY annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $3.68B | -$422.00M | -$598.00M | 10-K |
| 2024-12-31 | $3.79B | -$879.00M | -$910.00M | 10-K |
| 2023-12-31 | $3.96B | -$85.00M | -$132.00M | 10-K |
| 2022-12-31 | $3.92B | -$937.00M | -$950.00M | 10-K |
| 2021-12-31 | $4.23B | $608.00M | $411.00M | 10-K |
| 2020-12-31 | $3.34B | -$3.00M | -$73.00M | 10-K/A |
XRAY annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $5.43B | $4.09B | $1.34B | 10-Q |
| 2024-12-31 | $5.75B | $3.81B | $1.94B | 10-K |
| 2023-12-31 | $7.37B | $4.08B | $3.29B | 10-K |
| 2022-12-31 | $7.64B | $3.83B | $3.81B | 10-K |
| 2021-12-31 | $9.24B | $4.24B | $5.00B | 10-K/A |
| 2020-12-31 | $9.35B | $4.42B | $4.93B | 10-K/A |
XRAY annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $235.00M | -$131.00M | -$80.00M | 10-K |
| 2024-12-31 | $461.00M | -$180.00M | -$302.00M | 10-K |
| 2023-12-31 | $377.00M | -$149.00M | -$307.00M | 10-K |
| 2022-12-31 | $517.00M | -$149.00M | -$329.00M | 10-K |
| 2021-12-31 | $657.00M | -$142.00M | -$379.00M | 10-K |
| 2020-12-31 | $649.00M | -$87.00M | $476.00M | 10-K/A |